THIS EXPERIMENTAL FEATURE IS CURRENTLY IN BETA
Information may change without notice  |  Send comments to trials(at)BusaConsultingLLC(dot)com

SCSI Clinical Trials Monitor

The Monitor is an automated system providing real-time tracking of FDA-authorized stem cell clinical trials sponsored by the 16 component companies comprising the SCSI Stem Cell Stock Index.

Please see the accompanying Organelles article, Introducing the SCSI Clinical Trials Monitor: A Powerful New Current Awareness Tool for a detailed discussion of what the Monitor is (and is not), as well as a quick tutorial on its use. Quick-start tip: click any clinical trial's green/yellow/red flag icon, or its "Details" link to view a detailed analysis of that trial. Flags assigned here are provided as aids to the reader in scanning the list of trials; they are not predictions regarding a clinical trial's ultimate success or failure.

Purchasers of our industry report receive real-time email or text alerts of trial record changes and flag assignments as they happen.

Flag Key:
 No issues;   Possible minor issue(s);   Possible major issue(s)

Company Brief Title Phase End
Date
[1]
FDA Info Last
Update
Views
Rank
Summary
Flag
 
Aastrom
Biosciences
Ixmyelocel-T in
Heart Failure
2Aug
2015
NCT01670981Feb 25
2014
-Red Flag - Serious Issue? Details 
Advanced
Cell Tech.
MA09-hRPE in
Macular Dystrophy
1/2Jul
2013
NCT01345006Feb 1
2013
-Red Flag - Serious Issue? Details 
Advanced
Cell Tech.
hESC-RPE in
Macular Dystrophy
1/2Jan
2014
NCT01469832Feb 1
2013
-Red Flag - Serious Issue? Details 
Advanced
Cell Tech.
MA09-hRPE in Dry
Macular Dystrophy
1/2Jan
2014
NCT01344993Feb 1
2013
8thRed Flag - Serious Issue? Details 
AthersysMultiStem in
Ischemic Stroke
2Jun
2014
NCT01436487Feb 28
2014
5thRed Flag - Serious Issue? Details 
Athersys
(Pfizer)
MultiStem in
Ulcerative Colitis
2Apr
2014
NCT01240915Mar 3
2014
2ndYellow Flag - Minor Issue? Details 
Athersys
(Regensburg)
MultiStem for
Immunomod.
1Apr
2015
NCT01841632Apr 25
2013
-Green Flag - No Issues Details 
bluebird
bio
Genetic
engineered HSCs
for CCALD
2/3Aug
2018
NCT01896102Aug 28
2013
9thRed Flag - Serious Issue? Details 
bluebird
bio
Genetic
engineered HSCs
for Thalassemia
1/2Jul
2017
NCT01745120Nov 12
2013
-Red Flag - Serious Issue? Details 
BrainStorm
Cell Ther.
MSC-NTF for
ALS
2Oct
2015
NCT02017912Dec 17
2013
-Red Flag - Serious Issue? Details 
BrainStorm
Cell Ther.
(Hadassah)
MSC-NTF in
ALS
1/2Dec
2012
NCT01051882Nov 6
2013
-Red Flag - Serious Issue? Details 
BrainStorm
Cell Ther.
(Hadassah)
MSC-NTF in
ALS
2Sep
2014
NCT01777646Feb 4
2014
-Red Flag - Serious Issue? Details 
Capricor
Therapeutics
CDCs for
myocardial
infarction
1/2Oct
2015
NCT01458405Feb 18
2014
-Green Flag - No Issues Details 
Cytomedix
(Aldagen)
ALD-401 in
Ischemic Stroke
2Jul
2014
NCT01273337Jan 15
2014
3rdRed Flag - Serious Issue? Details 
Cytomedix
(Aldagen)
Cord Blood in
Lyso. Storage Dis.
1Dec
2014
NCT01003912Nov 5
2013
-Red Flag - Serious Issue? Details 
Cytomedix
(Aldagen)
ALDHbr for Cardiac
Angiogenesis
1n/aNCT00314366Sep 18
2013
-Red Flag - Serious Issue? Details 
Cytomedix
(Aldagen)
ALDHbr for Interm.
Claudication
2Nov
2014
NCT01774097Dec 2
2013
-Red Flag - Serious Issue? Details 
Cytomedix
(Aldagen)
ALD-101 for
Metab. Diseases
2n/aNCT00654433Sep 18
2013
-Red Flag - Serious Issue? Details 
CytoriASCs for Myo. Infarct1Apr
2012
NCT00442806Nov 25
2013
-Green Flag - No Issues Details 
CytoriASCs for Myo.
Ischemia
1/2May
2014
NCT01556022Jan 30
2014
-Red Flag - Serious Issue? Details 
CytoriASCs for Ischemic
Myocardium
1Mar
2012
NCT00426868Aug 27
2013
-Green Flag - No Issues Details 
CytoriASCs for Myo.
Infarction
2May
2015
NCT01216995Nov 25
2013
4thRed Flag - Serious Issue? Details 
CytoriASCs for
Hamstring Tear
1/2Dec
2015
NCT02045888Jan 23
2014
-Red Flag - Serious Issue? Details 
CytoriASCs for Myocardial
Ischemia
2Dec
2014
NCT02052427Jan 30
2014
-Red Flag - Serious Issue? Details 
Fate
Therapeutics
ProHema for
Cord Blood
Modulation
2May
2013
NCT00890500Oct 7
2013
-Green Flag - No Issues Details 
Fate
Therapeutics
ProHema for
Cord Blood
Modulation
2May
2015
NCT01627314Oct 25
2013
-Red Flag - Serious Issue? Details 
Fate
Therapeutics
FT1050 for
Cord Blood
Modulation
1Oct
2013
NCT01527838Oct 7
2013
-Red Flag - Serious Issue? Details 
NeoStem
(Amorcyte)
AMR-001 for Myo.
Infarction
2Jun
2014
NCT01495364Dec 19
2013
7thRed Flag - Serious Issue? Details 
NeoStem
(Emory Univ.)
AMR-001 for Myo.
Infarction
1Mar
2009
NCT00313339Nov 15
2013
-Green Flag - No Issues Details 
NeuralstemNSCs for Spinal
Cord Injury
1Feb
2016
NCT01772810Jan 3
2014
10thRed Flag - Serious Issue? Details 
NeuralstemNSCs for ALS1Jun
2014
NCT01348451Jan 6
2014
-Yellow Flag - Minor Issue? Details 
NeuralstemNSCs for ALS2Feb
2014
NCT01730716Jan 6
2014
-Red Flag - Serious Issue? Details 
OsirisProchymal for
Myo. Infarction
2Dec
2011
NCT00877903Jul 2
2012
-Yellow Flag - Minor Issue? Details 
OsirisProchymal for
Crohn's Disease
3Jan
2014
NCT01233960Jan 15
2014
-Red Flag - Serious Issue? Details 
OsirisProchymal for
T1 Diabetes
2Dec
2010
NCT00690066Feb 7
2011
-Red Flag - Serious Issue? Details 
OsirisProchymal for
Crohn's Disease
3Jan
2014
NCT00482092Jan 15
2014
6thRed Flag - Serious Issue? Details 
PluristemPLX-PAD after
Hip Arthroplasty
1/2Mar
2014
NCT01525667Aug 27
2013
-Yellow Flag - Minor Issue? Details 
PluristemPLX-PAD for Interm.
Claudication
2Dec
2015
NCT01679990Dec 9
2013
-Yellow Flag - Minor Issue? Details 
Pluristem
(United
Therapeutics)
PLX-PAD for PAH1Mar
2015
NCT01795950Jan 8
2014
-Red Flag - Serious Issue? Details 
StemCellsHuCNS-SC for
Macular
Degeneration
1/2Apr
2014
NCT01632527Jan 21
2014
-Red Flag - Serious Issue? Details 
StemCellsHuCNS-SC for Spinal
Cord Injury
1/2Dec
2015
NCT01321333Jan 21
2014
-Green Flag - No Issues Details 
ThermoGenesis
(TotipotentSC)
MB-MNCs for
Limb Ischemia
1/2Sep
2013
NCT01472289Sep 3
2013
-Red Flag - Serious Issue? Details 
ThermoGenesis
(Xuanwu Hosp.)
BM-MNCs for
Limb Ischemia
1/2Apr
2012
NCT01446055Oct 11
2011
1stRed Flag - Serious Issue? Details 

1. The "End Date" listed here is the "Primary Completion Date" (either "Anticipated" or "Actual") most recently provided by the sponsor to the FDA. A trial's Primary Completion Date is the date by which all patients will have received treatment and all patient data assessing achievement of the trial's Primary Endpoint(s) will have been collected. A trial's sponsor typically announces preliminary trial results shortly following its actual Primary Completion Date, although a trial is not fully completed until its subsequent Last Follow-Up Date.

The SCSI Clinical Trials Monitor is patent pending.